Eli Lilly reports Mounjaro revenue of $10.7B in 3Q
Story updates
10:48:58 AM UTC
SquawkNews
LILLY Q3 MOUNJARO REV $10.72 BLN VS IBES ESTIMATE $10.16 BLN
Related stories
Tokyo Electron First-Half Operating Income Jumps 67% to 506.78 Billion Yen
M impact | EARNINGS | Oct 30, 2026, 06:51 AM UTC
Stora Enso Q3 sales fall 2% on divestments
M impact | EARNINGS | Oct 30, 2026, 06:41 AM UTC
TAIEX Hits Over 2-Month Low, Suffers Monthly Loss
The TAIEX, Taiwan’s benchmark stock index, slumped 1,157 points, or 2.5%, to close at 45,212 on Friday, extending losses from the previous session and tracking a sharp fall in US s
H impact | EARNINGS | Oct 30, 2026, 06:40 AM UTC
Nxera Pharma Reports Third-Quarter 2026 Results
Nxera Pharma published operational highlights and consolidated results for the third quarter of 2026.
M impact | EQUITY | Oct 30, 2026, 06:38 AM UTC
Offshore Yuan Strongest Since 2022
The offshore yuan traded around 6.65 per dollar, reaching its strongest level since April 2022, supported by robust export growth and exporters converting dollar holdings into yuan
L impact | EARNINGS | Oct 30, 2026, 06:37 AM UTC
Sanofi Adjusted EPS Rises 22% in Q3 2026
Sanofi reported adjusted earnings per share for the third quarter of 2026, up 22%.
M impact | EARNINGS | Oct 30, 2026, 06:35 AM UTC